Free Trial

13,067 Shares in Henry Schein, Inc. (NASDAQ:HSIC) Acquired by Oppenheimer Asset Management Inc.

Henry Schein logo with Medical background
Remove Ads

Oppenheimer Asset Management Inc. purchased a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 13,067 shares of the company's stock, valued at approximately $904,000.

A number of other institutional investors have also made changes to their positions in HSIC. Farther Finance Advisors LLC increased its position in shares of Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock valued at $68,000 after acquiring an additional 346 shares during the last quarter. Radnor Capital Management LLC acquired a new position in shares of Henry Schein in the third quarter valued at approximately $1,100,000. Principal Financial Group Inc. grew its holdings in shares of Henry Schein by 2.1% in the third quarter. Principal Financial Group Inc. now owns 145,835 shares of the company's stock valued at $10,631,000 after purchasing an additional 3,037 shares in the last quarter. Olstein Capital Management L.P. grew its holdings in shares of Henry Schein by 8.1% in the third quarter. Olstein Capital Management L.P. now owns 93,000 shares of the company's stock valued at $6,780,000 after purchasing an additional 7,000 shares in the last quarter. Finally, Covestor Ltd grew its holdings in shares of Henry Schein by 31.2% in the third quarter. Covestor Ltd now owns 1,987 shares of the company's stock valued at $144,000 after purchasing an additional 473 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on HSIC. Mizuho began coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price objective for the company. UBS Group dropped their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Barrington Research restated an "outperform" rating and issued a $90.00 price objective on shares of Henry Schein in a report on Wednesday, February 26th. Jefferies Financial Group lifted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Finally, Wells Fargo & Company assumed coverage on shares of Henry Schein in a research note on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price target for the company. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Henry Schein has a consensus rating of "Moderate Buy" and an average target price of $81.10.

Remove Ads

View Our Latest Analysis on Henry Schein

Henry Schein Price Performance

NASDAQ HSIC traded up $1.63 during trading hours on Friday, reaching $74.59. The company's stock had a trading volume of 2,145,365 shares, compared to its average volume of 1,487,644. The stock has a market cap of $9.26 billion, a PE ratio of 30.70, a PEG ratio of 2.13 and a beta of 0.91. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The company's 50-day moving average is $74.48 and its two-hundred day moving average is $72.51. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to analysts' expectations of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the company posted $0.66 earnings per share. Analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Stories

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads